Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile
Tài liệu tham khảo
Schweppe, 2001, Current place of progestins in the treatment of endometriosis-related complaints, Gynecol Endocrinol, 15, 22, 10.1080/gye.15.s6.22.28
Oettel, 1999, The preclinical and clinical profile of dienogest. A short overview, Drugs Today, 35, 3
Rowlands, 2003, Newer progestogens, J Fam Plann Reprod Health Care, 29, 13, 10.1783/147118903101197188
Sitruk-Ware, 2004, Pharmacological profile of progestins, Maturitas, 47, 277, 10.1016/j.maturitas.2004.01.001
Oettel, 1995, A 19-norprogestin without 17α-ethinyl group II: dienogest from a pharmacodynamic point of view, Drugs Today, 31, 517
Moore, 1999, The treatment of endometriosis with dienogest, Drugs Today, 35, 41
Cosson, 2002, Dienogest is as effective as triptorelin in the treatment of endometriosis after laparoscopic surgery: results of a prospective, multicenter, randomized study, Fertil Steril, 77, 684, 10.1016/S0015-0282(01)03270-8
Schindler, 2006, High-dose pilot study with the novel progestogen dienogest in patients with endometriosis, Gynecol Endocrinol, 22, 9, 10.1080/09513590500431482
Crosignani, 2006, Advances in the management of endometriosis: an update for clinicians, Hum Reprod Update, 12, 179, 10.1093/humupd/dmi049
Koch, 1982, Further report on the endocrinological profile of 17 alpha-cyanomethyl-17 beta-hydroxy-estra-4,9(10)-diene-3-one (STS 557) in rodents, Endokrinologie, 79, 173
Hillesheim, 1989, Pharmacokinetics of the progestin dienogest (STS 557) in rabbits, Exp Clin Endocrinol, 94, 194, 10.1055/s-0029-1210897
Furutani, 2002, Stabilization of androgen receptor protein is induced by agonist, not by antagonists, Biochem Biophys Res Commun, 294, 779, 10.1016/S0006-291X(02)00564-8
Fuse, 2000, Characterization of transactivational property and coactivator mediation of rat mineralocorticoid receptor activation function-1 (AF-1), Mol Endocrinol, 14, 889, 10.1210/me.14.6.889
Kitagawa, 2002, Ligand-selective potentiation of rat mineralocorticoid receptor activation function 1 by a CBP-containing histone acetyltransferase complex, Mol Cell Biol, 22, 3698, 10.1128/MCB.22.11.3698-3706.2002
Kobayashi, 2000, p300 mediates functional synergism between AF-1 and AF-2 of estrogen receptor alpha and beta by interacting directly with the N-terminal A/B domains, J Biol Chem, 275, 15645, 10.1074/jbc.M000042200
Kastner, 1990, Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B, Embo J, 9, 1603, 10.1002/j.1460-2075.1990.tb08280.x
Green, 1987, Oestradiol induction of a glucocorticoid-responsive gene by a chimaeric receptor, Nature, 325, 75, 10.1038/325075a0
Tora, 1989, The cloned human oestrogen receptor contains a mutation which alters its hormone binding properties, EMBO J, 8, 1981, 10.1002/j.1460-2075.1989.tb03604.x
Govindan, 1985, Cloning of the human glucocorticoid receptor cDNA, Nucleic Acids Res, 13, 8293, 10.1093/nar/13.23.8293
Matsui, 2002, Transcriptional regulation of the mouse steroid 5alpha-reductase type II gene by progesterone in brain, Nucleic Acids Res, 30, 1387, 10.1093/nar/30.6.1387
Yamamoto, 2001, The tamoxifen-responsive estrogen receptor alpha mutant D351Y shows reduced tamoxifen-dependent interaction with corepressor complexes, J Biol Chem, 276, 42684, 10.1074/jbc.M107844200
Nisula, 1979, Measurement of the testosterone binding parameters for both testosterone-estradiol binding globulin and albumin in individual serum samples, Steroids, 34, 771, 10.1016/0039-128X(79)90090-4
Vermeulen, 1974, Hormonal contraceptives and carbohydrate tolerance. II. Influence of medroxyprogesterone acetate and chronic oral contraceptives, Diabetologia, 10, 253, 10.1007/BF02627727
Fahraeus, 1984, Plasma lipoproteins during and after danazol treatment, Acta Obstet Gynecol Scand Suppl, 123, 133, 10.3109/00016348409157000
Nikschick, 1989, Carbohydrate metabolism during treatment of endometriosis with the progestin dienogest, Exp Clin Endocrinol, 94, 211, 10.1055/s-0029-1210899
Herkert, 2001, Sex steroids used in hormonal treatment increase vascular procoagulant activity by inducing thrombin receptor (PAR-1) expression: role of the glucocorticoid receptor, Circulation, 104, 2826, 10.1161/hc4801.099737
Larrea, 2001, A-ring reduced metabolites of 19-nor synthetic progestins as subtype selective agonists for ER α, Endocrinology, 142, 3791, 10.1210/en.142.9.3791
Oelkers, 2004, Drospirenone, a progestogen with antimineralocorticoid properties: a short review, Mol Cell Endocrinol, 217, 255, 10.1016/j.mce.2003.10.030
Pugeat, 1981, The significance of drug interactions with human TeBG and CBG under physiological conditions: a new approach, J Steroid Biochem, 15, 487, 10.1016/0022-4731(81)90319-8
Nilsson, 1983, Free testosterone levels during danazol therapy, Fertil Steril, 39, 505, 10.1016/S0015-0282(16)46941-4
Forbes, 1986, Dosage-related effects of danazol on sex hormone binding globulin and free and total androgen levels, Clin Endocrinol (Oxf), 25, 597, 10.1111/j.1365-2265.1986.tb03614.x
Oettel, 1995, A 19-norprogestin without a 17α-ethinyl group I: dienogest from a pharmacokinetic point of view, Drugs Today, 31, 499
Ottosson, 1985, Effects of progesterone, progestogens, and danazol on the specific cortisol binding in human plasma, Fertil Steril, 43, 856, 10.1016/S0015-0282(16)48612-7